T cells in HBV associated hepatocellular carcinoma and other cancers
Individuals with HBV associated hepatocellular carcinoma or other cancers are characterized by dysfunctional anti-virus and anti-tumor T-cell responses. Since noteworthy benefits of inhibitory pathway blockades, such as PD-1 inhibitor or CTLA-4 inhibitor have been achieved in multiple advanced cance...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Oxford
2017
|
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.748866 |